Mark Kohr
Has grant
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Impact of arsenic exposure on in vitro cardiac development and function
Open Date: 2026-01-01
Close Date: 2027-01-01
Grant: Close
Formate: friend or foe in the heart?
Open Date: 2024-01-01
Close Date: 2026-01-01
Grant: Close
The impact of sex-dependent glycosylation on nitros(yl)ation in myocardial infarction
Open Date: 2024-01-01
Close Date: 2026-01-01
Grant: Close
Role of formaldehyde, formate and one-carbon metabolism in the female heart
Open Date: 2021-08-20
Close Date: 2025-07-31
Grant: Close
S-nitrosoglutathione reductase in the aging heart
Open Date: 2020-01-01
Close Date: 2021-01-01
Articles (7)
GSNOR deficiency appears beneficial to cardiac aging in both sexes, but at the cellular level, we discovered a sex disparity and the potential for underlying cellular dysfunction in female hearts. Taken together, GSNOR deficiency may present a mechanism through which the female heart specifically is at a higher risk of age-related cardiovascular disease and may represent a potential clinical target.
Year:
2026
Year:
2026
Ischemic heart disease is a leading cause of death for both men and women in the United States. We and others have demonstrated that nitric oxide (NO) signaling and associated protein S-nitrosation (SNO) play a key role in reducing ischemic injury in the heart. We also find that while females typically exhibit endogenous protection from ischemic injury, this protection is abrogated with the loss of the formate-generating enzyme alcohol dehydrogenase 5 (ADH5), but formate supplementation provided a rescue. Here, we investigate the cardioprotective efficacy of formate in male hearts. Hearts were Langendorff-perfused and subjected to ischemia/reperfusion (I/R) injury with and without formate. Formate-mediated protection was also examined using an in vitro model of coverslip-induced ischemic injury to identify molecular underpinnings. We found that formate yields protection from I/R injury in ex vivo and in vitro models by increasing post-ischemic protein SNO levels, while NO synthase inhibition blocked this formate-mediated increase in protein SNO in vitro, and attenuated protection from I/R injury ex vivo. Moreover, post-ischemic levels of tetrahydrobiopterin (BH4), a cofactor necessary for NOS function, were preserved in formate-treated hearts. Furthermore, inhibition of dihydrofolate reductase (DHFR), a one-carbon enzyme critical for BH4 recycling, blunted formate-mediated protection ex vivo. Collectively, our findings suggest that formate is a potent cardioprotective agent that confers protection by preserving post-ischemic BH4 levels, and enhancing protein SNO levels through a NOS-dependent mechanism. These findings have significant implications for the clinical prevention and treatment of ischemic heart disease in males.
Year:
2026
Gestational exposure to sodium arsenite at environmentally relevant doses (100 and 1,000 µg/L) increases postpartum heart size, and induces dysregulated Ca 2+ homeostasis and impaired shortening in isolated cardiomyocytes. This is the first study to demonstrate that gestational arsenic exposure impacts postpartum heart structure and function beyond the exposure period.
Year:
2025
Ischemic heart disease is a primary cause of death for men and women in the United States. Recent epidemiologic findings, however, suggest that premenopausal women have inherent protection from many cardiovascular pathologies compared to age‐matched men, which is lost with menopause. We and others have documented similar protective signaling in animal models, with females exhibiting protection from ischemic injury that is lost with ovariectomy (OVX). Furthermore, in recent studies, we demonstrated that the loss of alcohol dehydrogenase 5 (ADH5) blocked sex‐specific cardioprotection in females, but activation of aldehyde dehydrogenase 2 (ALDH2) provided a rescue. ADH5 and ALDH2 both metabolize formaldehyde to formate, potentially implicating formate in female‐specific cardioprotection. Therefore, the objective of this study was to examine a role for formate during ischemic injury in female hearts using wild‐type (WT) and ADH5 −/− mice. We also aimed to explore estrogen‐dependent effects by using ovariectomized (OVX) WT mice. To assess the protective effects of formate in intact WT and ADH5 −/− female mice, as well as OVX WT female mice, hearts were Langendorff‐perfused and subjected to ischemia/reperfusion (I/R) injury. Since formate is used in one‐carbon metabolism (OCM), select OCM enzymes were also probed via western blot. Importantly, we found that formate significantly reduced infarct size in intact ADH5 −/− female hearts subjected to I/R injury, but formate was without effect in intact WT female hearts. Additionally, formate failed to reduce I/R injury in OVX WT female hearts, despite OVX WT female hearts exhibiting reduced ADH5 and ALDH2 activity. However, we noted that the expression of certain OCM enzymes was downregulated in OVX WT female hearts versus intact WT females, which may prevent proper formate utilization by OCM in OVX WT female hearts. Furthermore, blockage of formate import into OCM in intact WT female hearts also exacerbated I/R injury. Taken together, our findings support formate utilization by OCM as a key component of cardioprotective signaling in female hearts, with estrogen acting as a potential mediator.
Year:
2025
Year:
2025
Background Environmental exposure to heavy metals such as lead (Pb), arsenic (As), hexavalent chromium [Cr(VI)], and cadmium (Cd), (PACC), is linked to neurodevelopmental disorders. These metals often co-occur in contaminated environments, but their combined effects on brain development remain poorly understood. Objective To test the hypothesis that perinatal exposure to a mixture of environmentally relevant levels of Pb, As, Cd, and Cr(VI), causes developmental defects in cognition, behavior, and neuronal function. Methods Female C57BL/6J mice were exposed to either a single metal or the PACC mixture in drinking water. Exposure began two weeks preconception and continued until weaning at postnatal day 21. Juvenile mice were tested at 4–5 weeks of age in open field (locomotion), novel object recognition (short-term memory), Y-maze (working memory), and elevated plus maze (anxiety-like behavior). A subset of animals underwent Whole-cell patch-clamp recordings in the medial prefrontal cortex (mPFC) and hippocampal CA1 neurons. Results Perinatal exposure to PACC metal mixture increased anxiety-like behavior and impaired short-term memory but not locomotion or working memory. Pyramidal neurons in mPFC and hippocampal CA1 displayed increased intrinsic excitability, mPFC neurons also showed elevated amplitude in spontaneous excitatory postsynaptic currents. Discussion Our findings suggest that perinatal exposure to the PACC metal mixture impairs cognition, increases anxiety-like behavior, and alters neuronal function in specific brain regions of juvenile mice, leading to disruption in neuronal function and behavior later in life. Further studies are needed to provide mechanistic insight into how perinatal heavy metal exposure affects neuronal development. Highlights Perinatal exposure to a metal mixture including lead (Pb), arsenic (As), hexavalent chromium (Cr(VI)), and cadmium (Cd), collectively termed PACC metal mixture—impairs cognition and increases anxiety in mice. Neuronal excitability and synaptic transmission are altered in medial prefrontal cortex after PACC metal mixture exposure. PACC mixture exposure decreases short-term memory in both males and females, and increases anxiety in males Principal component and clustering analyses reveal that PACC mixture exposure and control mice form distinct, nonoverlapping populations in physiological-behavioral space. Environmentally relevant PACC metal mixtures exert stronger effects than individual metals alone.
Year:
2025
Collaborators (8)
Fenna Sille
Assistant Professor
Johns Hopkins University Bloomberg School of Public Health
Brian O'Rourke
Professor
Johns Hopkins University School of Medicine
Mark Crabtree
Head of the Clinical Sciences Discipline / Senior Lecturer
University of Oxford
Laura Elizabeth Brewer Riess
Johns Hopkins University
Austin Graves
Research Assistant Professor
Johns Hopkins University
Keeve Nachman
Professor
Johns Hopkins University Bloomberg School of Public Health
Shyam Biswal
Professor
Johns Hopkins University
Brian Lin
Assistant Professor
Medical College of Wisconsin
Make your next move.
Prepare your application
Review drafts before you send them.